Searched for
BIOLOGICAL E APPROVAL
Curb your overenthusiasm: Why India must avoid early overregulation while drafting rules for new techIndia faces a critical choice in regulating new industries like AI and genomics. Overly cautious, ex-ante regulations, similar to the histo...- Biological E seeks nod for bivalent vax trialsBiological E has developed the protein subunit Covid vaccine Corbevax. The antigen used in the vaccine was developed by Texas Children’s Ho...
- Biological E's Pneumonia jab for kids gets nodStreptococcus pneumoniae infection is a leading cause of child mortality under 5 years of age in India and other developing countries.
- Vaccinated with Covaxin or Covishield? You may take Corbevax as precaution doseThe government has approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield o...
- Covid shots for 5-12-year kids not yet included in vaccine driveThe NTAGI has approved both vaccines, but has not recommended the government to put those in the immunisation drive, people in the know tol...
- Biocon Biologics' arm gets USD 90 mn contract from Malaysian government for supply of insulinsBiocon Biologics, a part of Biocon Ltd, has created a Centre of Excellence (CoE) for insulins in Malaysia with end-to-end capabilities to m...
- Biological E. COVID shot gets India emergency approval for 12-18 age groupThe company's shot, called Corbevax, is the third vaccine approved for use in children aged 12 and above in India, joining Zydus Cadila's D...
- Subject Expert Committee recommends EUA for BE's Covid jab Corbevax for 12-18 years age groupCorbevax, is a RBD protein sub-unit vaccine that has been developed with support from the Department of Biotechnology and the Biotechnology...
- Biological E seeks EUA for its Corbevax vaccine for 12-18 yrs age groupThe Drugs Controller General Of India (DCGI) has already approved Corbevax, which is India's first indigenously developed RBD protein sub-u...
- Experts panel to review applications of Covovax & Corbevax jabs; Merck's Covid drug todayThe subject experts committee (SEC), a body under India's drug regulator, will meet on Monday to review the applications for granting appro...
- New Covid vaccine: Bio E may submit Corbevax trial data this monthThe government had estimated that Biological would account for 300 million jabs from August to December.
- Indemnity issues may hold up availability of J&J single dose vaccineWhile the drug regulator has given a nod to Biological E to manufacture the vaccine at its plant in Telangana, its launch looks unlikely ti...
- Biological E gets nod for phase 2/3 clinical trial of its Covid vaccine on children above 5 years, adolescentsThe approval for conducting phase III comparator safety and immunogenicity trial in adults came after the SEC's review of Phase I and II cl...
- Centre inks deal with Hyderabad-based Biological-E for second Made-In-India Covid shotThe vaccine, which is currently undergoing phase-3 clinical trials, is likely to be available in the next few months, the health ministry s...
- India's Biological E. to make Providence Therapeutics' mRNA COVID-19 vaccineProvidence will sell up to 30 million doses of its mRNA vaccine, PTX-COVID19-B, to Biological E., and will also provide the necessary techn...
- J&J awaiting DCGI nod for bridging trial of one-dose jabIt is unclear why J&J wants to conduct a bridging trial in India despite regulations in India allowing easy access to vaccines that have re...
- Biological E jabs may hit market by August, says Dr VK PaulAs per the ICMR , Biological E is testing a two-dose vaccine. Similar to Bharat Biotech’s Covaxin, Biological E’s vaccine under trial presc...
- Biological E may fill global supply gaps of Johnson & Johnson jabsIndia may have to wait for bridging trialJ&J’s deal with Biological E is a global supply agreement and the company will be tapped to meet c...
- Drug regulator approves Hyderabad-based Biological E's phase I/II trials of Covid vaccineBiological E has tied up with an undisclosed company and will be conducting the trials. The announcement about the tie up is likely to be m...
- GlaxoSmithKline Biologicals in talks to buy BE's vaccine divisionThis division produces and markets a range of paediatric and adult vaccines and has a sizeable market share in the Indian vaccine market.
Load More
